Literature DB >> 19217807

Postconditioning: current controversies and clinical implications.

K A Mockford1, H R S Girn, S Homer-Vanniasinkam.   

Abstract

OBJECTIVES: Postconditioning of ischaemic tissue, via mechanical or pharmacological manipulation, offers an exciting avenue towards amelioration of ischaemia-reperfusion injury. Born from the concept of ischaemic preconditioning, postconditioning is advantageous in that prior knowledge of the ischaemic insult is not required, and thus clinical translation may be further reaching. This review explores the current evidence and controversies in both animal and human studies and multiple organ systems.
METHODS: A Medline search was conducted to identify English-language articles with 'postconditioning' as a keyword. Two independent researchers scrutinised the literature search for potentially relevant articles. Reference lists from selected articles were manually searched for further relevant articles. RESULTS AND
CONCLUSIONS: Postconditioning has been shown to be successful in reducing ischaemia-reperfusion injury in both animal models and clinical trials. Human studies are presently limited to cardiac studies, but there is scope for research into other organ systems with potential beneficial effects, particularly within the field of vascular surgery where ischaemia-reperfusion occurs by nature of both - the disease and the intervention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217807     DOI: 10.1016/j.ejvs.2008.12.017

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  8 in total

1.  Tacolimus postconditioning alleviates apoptotic cell death in rats after spinal cord ischemia-reperfusion injury via up-regulating protein-serine-threonine kinases phosphorylation.

Authors:  Feng Pan; Yan-Xiang Cheng; Cheng-Liang Zhu; Feng-Hua Tao; Zhang-Hua Li; Hai-Ying Tao; Bin He; Ling Yu; Peng Ji; Huan Tang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

2.  Comparison of cardioprotective and anti-inflammatory effects of ischemia pre- and postconditioning in rats with myocardial ischemia-reperfusion injury.

Authors:  Jun Xiong; Qiang Wang; Fu-Shan Xue; Yuan-Jing Yuan; Shan Li; Jian-Hua Liu; Xu Liao; Yan-Ming Zhang
Journal:  Inflamm Res       Date:  2010-12-31       Impact factor: 4.575

Review 3.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

Review 4.  Heart transplantation with donation after circulatory determination of death.

Authors:  Sarah L Longnus; Veronika Mathys; Monika Dornbierer; Florian Dick; Thierry P Carrel; Hendrik T Tevaearai
Journal:  Nat Rev Cardiol       Date:  2014-04-15       Impact factor: 32.419

5.  Protective effect of ischemic postconditioning against hepatic ischemic reperfusion injury in rat liver.

Authors:  Sam-Youl Yoon; Chung Yun Kim; Hyung Joon Han; Kun Ok Lee; Tae-Jin Song
Journal:  Ann Surg Treat Res       Date:  2015-04-30       Impact factor: 1.859

6.  Postconditioning in major vascular surgery: prevention of renal failure.

Authors:  Peter Aranyi; Zsolt Turoczi; David Garbaisz; Gabor Lotz; Janos Geleji; Viktor Hegedus; Zoltan Rakonczay; Zsolt Balla; Laszlo Harsanyi; Attila Szijarto
Journal:  J Transl Med       Date:  2015-01-27       Impact factor: 5.531

7.  Influence of levosimendan postconditioning on apoptosis of rat lung cells in a model of ischemia-reperfusion injury.

Authors:  Chengxin Zhang; Zhixiang Guo; Haiyuan Liu; Yinglu Shi; Shenglin Ge
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

8.  Exogenous hydrogen sulfide restores cardioprotection of ischemic post-conditioning via inhibition of mPTP opening in the aging cardiomyocytes.

Authors:  Hongzhu Li; Chao Zhang; Weiming Sun; Lina Li; Bo Wu; Shuzhi Bai; Hongxia Li; Xin Zhong; Rui Wang; Lingyun Wu; Changqing Xu
Journal:  Cell Biosci       Date:  2015-07-30       Impact factor: 7.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.